Pegylation modulates ApoE association and hepatic accumulation of DC-Chol-based nanoparticles through steric exclusion.

Hosseini-Kharat M, Wignall A, Chereda B, Parkinson-Lawrence E, Bremmell KE, Prestidge CA

Open source

DOI
10.1016/j.ijpharm.2026.127357
Published
2026 Oct 5
Container
International journal of pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.127357,
  title = {Pegylation modulates ApoE association and hepatic accumulation of DC-Chol-based nanoparticles through steric exclusion.},
  author = {Hosseini-Kharat M and Wignall A and Chereda B and Parkinson-Lawrence E and Bremmell KE and Prestidge CA},
  year = {2026},
  journal = {International journal of pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.127357},
  url = {https://doi.org/10.1016/j.ijpharm.2026.127357}
}

RIS

TY  - JOUR
TI  - Pegylation modulates ApoE association and hepatic accumulation of DC-Chol-based nanoparticles through steric exclusion.
AU  - Hosseini-Kharat M
AU  - Wignall A
AU  - Chereda B
AU  - Parkinson-Lawrence E
AU  - Bremmell KE
AU  - Prestidge CA
PY  - 2026
JO  - International journal of pharmaceutics
DO  - 10.1016/j.ijpharm.2026.127357
UR  - https://doi.org/10.1016/j.ijpharm.2026.127357
ER  - 

APA

M, H., A, W., B, C., E, P., KE, B., & CA, P. (2026). Pegylation modulates ApoE association and hepatic accumulation of DC-Chol-based nanoparticles through steric exclusion.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127357

Source records